Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,870 | -20,428 | -10,317 | -7,279 | -3,563 |
| Depreciation Amortization | 158 | 663 | 505 | 324 | 162 |
| Other Working Capital | -672 | -319 | -207 | -64 | 316 |
| Other Operating Activity | -1,403 | 4,872 | 204 | 95 | 29 |
| Operating Cash Flow | $-4,787 | $-15,212 | $-9,815 | $-6,925 | $-3,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 11 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $11 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -179 |
| Common Stock Issued | 1 | 63,967 | 7,505 | 7,505 | 1,654 |
| Other Financing Activity | 0 | -448 | -408 | -292 | 0 |
| Financing Cash Flow | $1 | $63,519 | $7,097 | $7,213 | $1,474 |
| Exchange Rate Effect | 28 | 19 | 18 | 6 | 0 |
| Beginning Cash Position | 55,260 | 6,923 | 6,923 | 6,923 | 6,923 |
| End Cash Position | 50,502 | 55,260 | 4,224 | 7,217 | 5,341 |
| Net Cash Flow | $-4,758 | $48,337 | $-2,699 | $294 | $-1,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,787 | -15,212 | -9,815 | -6,925 | -3,056 |
| Free Cash Flow | -4,787 | -15,212 | -9,815 | -6,925 | -3,056 |